HealthWarehouse.com Reports Q3 Net Sales of $8.4 Million and Net Loss of $72,000

Reuters

Nov 13

HealthWarehouse.com Reports Q3 Net Sales of $8.4 Million and Net Loss of $72,000

HealthWarehouse.com Inc. reported net sales of $8.4 million for the third quarter ended September 30, 2025, a 7.0% decrease compared to the same period in 2024. The company recorded a net loss of $0.1 million and Adjusted EBITDA of $0.3 million for the quarter. Year-to-date sales totaled $39.1 million, representing a 97.0% increase over the prior year, with net income of $0.3 million and Adjusted EBITDA of $1.4 million. The company attributed the quarterly sales decline to slower direct-to-consumer sales and reduced sales of compounded GLP-1 prescription medications following changes in FDA approvals. HealthWarehouse.com highlighted positive cash flow and upcoming new product launches aimed at diversifying its catalog.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HealthWarehouse.com Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251112710392) on November 12, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2583583815"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2583583815\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2583583815?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-13 05:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2583583815","market":"fut","top_or_hot":-1,"title":"HealthWarehouse.com Reports Q3 Net Sales of $8.4 Million and Net Loss of $72,000","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      HealthWarehouse.com Reports Q3 Net Sales of $8.4 Million and Net Loss of $72,000\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        HealthWarehouse.com Inc. reported net sales of $8.4 million for the third quarter ended September 30, 2025, a 7.0% decrease compared to the same period in 2024. The company recorded a net loss of $0.1 million and Adjusted EBITDA of $0.3 million for the quarter. Year-to-date sales totaled $39.1 million, representing a 97.0% increase over the prior year, with net income of $0.3 million and Adjusted EBITDA of $1.4 million. The company attributed the quarterly sales decline to slower direct-to-consumer sales and reduced sales of compounded GLP-1 prescription medications following changes in FDA approvals. HealthWarehouse.com highlighted positive cash flow and upcoming new product launches aimed at diversifying its catalog.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HealthWarehouse.com Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251112710392) on November 12, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HealthWarehouse.com Reports Q3 Net Sales of $8.4 Million and Net Loss of $72,000</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHealthWarehouse.com Reports Q3 Net Sales of $8.4 Million and Net Loss of $72,000\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-13 05:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      HealthWarehouse.com Reports Q3 Net Sales of $8.4 Million and Net Loss of $72,000\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        HealthWarehouse.com Inc. reported net sales of $8.4 million for the third quarter ended September 30, 2025, a 7.0% decrease compared to the same period in 2024. The company recorded a net loss of $0.1 million and Adjusted EBITDA of $0.3 million for the quarter. Year-to-date sales totaled $39.1 million, representing a 97.0% increase over the prior year, with net income of $0.3 million and Adjusted EBITDA of $1.4 million. The company attributed the quarterly sales decline to slower direct-to-consumer sales and reduced sales of compounded GLP-1 prescription medications following changes in FDA approvals. HealthWarehouse.com highlighted positive cash flow and upcoming new product launches aimed at diversifying its catalog.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HealthWarehouse.com Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251112710392) on November 12, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HEWA","symbol_name":"HealthWarehouse.com, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL8s7Lkn:1","article_id":"2583583815","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2583583815","pubTimestamp":1762982217,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"HealthWarehouse.com Reports Q3 Net Sales of $8.4 Million and Net Loss of $72,000               HealthWarehouse.com Inc. reported net sales of $8.4 million for the third quarter ended September 30, 202","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HEWA":"HealthWarehouse.com, Inc.","BK4128":"药品零售","BK4122":"互联网与直销零售"},"translate_title":"HealthWarehouse.com报告第三季度净销售额为840万美元，净亏损为72,000美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HEWA":0.9},"content_text":"HealthWarehouse.com Reports Q3 Net Sales of $8.4 Million and Net Loss of $72,000\n    \n\n        HealthWarehouse.com Inc. reported net sales of $8.4 million for the third quarter ended September 30, 2025, a 7.0% decrease compared to the same period in 2024. The company recorded a net loss of $0.1 million and Adjusted EBITDA of $0.3 million for the quarter. Year-to-date sales totaled $39.1 million, representing a 97.0% increase over the prior year, with net income of $0.3 million and Adjusted EBITDA of $1.4 million. The company attributed the quarterly sales decline to slower direct-to-consumer sales and reduced sales of compounded GLP-1 prescription medications following changes in FDA approvals. HealthWarehouse.com highlighted positive cash flow and upcoming new product launches aimed at diversifying its catalog.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HealthWarehouse.com Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251112710392) on November 12, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}